This study documented bone loss at three different unit increase in BMI was associated with a~5% reduction in the rate of bone loss. Of the other sites in the early postmenopausal period, and examined potential predictors. Forty-three women undervariables measured (maximum oxygen consumption, lean body mass, fat mass, mean psoas muscle area went repeated measurements of bone density at the lumbar spine, proximal femur and distal radius for at the L3 level, hand grip strength as well as anthropometry) only bone densitometry was sufficiently up to 14 years. Individual rates of bone loss were calculated for the spine and hip; for radial trabecular predictive to help guidance on hormone replacement or other prophylactic therapy. The data suggest bone, rates were calculated separately for two time periods, earlier and later after menopause. In the that the known relationship between excessive leanness and risk of osteoporosis and vertebral fracture spine and radius, initially high rates of loss diminished with time after menopause. No positive corafter menopause might in part be due to fast postmenopausal bone loss. Because bulk of psoas muscle relations for bone loss were found between the three sites, suggesting that faster than average bone loss was associated with low spine loss rates, the data also support a role for applied muscular loading in was specific to individual bones. High body mass index (BMI) was significantly protective against fast local maintenance of bone density. bone loss at the spine and radius; in the spine, each
Introduction
Women lose bone from the spine after the menoappreciably.3 Many women are interested in taking HRT for prevention of osteoporosis only if they are pause at a rate several-fold faster than that in men of the same age or premenopausal women.
at higher than average risk of an osteoporotic fracture. Certain pharmaceutical approaches have been shown Furthermore, after age 50, rates of vertebral deformity increase faster in women than in men.1 This differto prevent postmenopausal bone loss, such as bisphosphonates and selective oestrogen receptor moduence can be largely attributed to the faster rate of decline in spinal bone mineral density in women.2 lators (SERMs) such as tibolone and raloxifene. However there remain concerns about the long-term There has been much interest in the possibility of preventing osteoporotic fractures by reducting use of these agents in prophylaxis as distinct from treatment of disease. postmenopausal bone loss. Hormone replacement therapy (HRT) prevents both bone loss and fractures, Future fracture risk is related to current bone density, which in turn is a function of premenopausal but not all women wish to take HRT for prolonged periods after the menopause, and after 5 years of bone density and its subsequent rate of loss. Black4 calculated that by age 70, premenopausal bone HRT the perceived risk of breast cancer increases density and cumulative postmenopausal bone loss were invited to join the study. Sixty-four accepted, giving an 80% response rate. Over the ensuing years contribute about equally to the between-individual up until their final bone density measurement, 17 variation in fracture risk. Hence there has been received hormone replacement therapy for 3 months considerable interest in developing methods for preor more at some stage. None had cervical cancer. dicting rates of bone loss in the two decades after
The daily calcium intakes of these women were menopause.
comparatively stable and ranged from 466 to There have been a number of long-term prospect-1882 mg/day (median 916) when assessed by ive studies of forearm bone density in peri-5 and weighed intake on two occasions approximately 5 postmenopausal women,6,7 but the technology of years apart.12 At the conclusion of these measuredual-photon absorptiometry, which made precise ments, the subjects were a median age of 64 (mean spinal measurements possible, became available 63.5, SD 2.7) years of age. The study was approved more than a decade after single-photon absorptiomeby the Harrow District Ethical Committee. try,8 delaying the generation of results from longterm cohort studies on the spine and hip. The Harrow postmenopausal bone loss study was begun in 1984
Lifestyle, anthropometric and musclewith the aim of documenting rates of spinal bone related variables loss in normal women recruited within three years At recruitment, each woman answered a simple of the menopause, in a community setting.9 Because questionnaire which included questions on selfrates of bone loss after the menopause are attenuated assessed smoking (yes/no; how many cigarettes per quite rapidly, so that women >5 years after the day), alcohol consumption (none/moderate/more menopause are losing bone less quickly than women than moderate) and exercise (recreational exercise within 2 years of the menopause,9,10 we previously yes/no). Height was measured on the same stadirelated bone loss to years since menopause rather ometer and weight on the same balance. Weight, than chronological age. In our first report, after 5 and on some occasions height, were remeasured at years of study, which included seven dual-photon each densitometry visit. absorptiometry (DPA) measurements per subject, difTotal body potassium was measured by whole ferences between women in their individual rates of body scintillation counting13 (40K) on three occasions spinal bone loss were on the borderline of statistical over the first 5 years of the study. On up to four significance. The purpose of the present paper is to occasions at yearly intervals, each woman had a CT provide a description of spinal, femoral and radial scan of the trunk at L3 level for measurement of trabecular bone loss over the first 11-14 post-BMD by QCT. These studies were begun before it menopausal years in the same population sample, was realized that the GE 9000 series machine used to demonstrate the extent to which individual women was sensitive for the measurement of BMD to table differed in their rates of bone loss after menopause, height, so the BMD trend data were not considered and if possible, to identify predictors of bone loss reliable. Because of the reported association of psoas from among variables measured at baseline which muscle weight with bone density,14 each scan was related to lifestyle, muscle mass, muscle strength and also analysed for the sum of the cross-sectional areas anthropometry.
of the left and right belly of the psoas muscle by manually tracing round the images of the two muscles to generate mean psoas area. Because
Methods maximum oxygen consumption, measured as VO 2 max, has been reported to be protective of bone Patients density after menopause,15,16 on one occasion at Women between 42 and 52 years of age from four approximately 3.5 years post-recruitment, each comprimary-care practices who had not had a hysterecpliant woman who was passed medically fit undertomy were invited to participate in a study of how took a treadmill test under medical supervision. After women lose spinal bone at the menopause. Women an habituation session followed by at least 5 min who had a history of malignancy were not interrest, subjects began walking at their pre-selected viewed, and the remainder were asked about the speed on a Powerjog treadmill with zero gradient. date of their last menstrual period. Those consenting After 3 min, gradient was increased in increments of who were between 9 and 36 months of their last between 1 and 5% every 2 min until the target heart menstrual period and in good general health were rate was achieved (85% of maximum, which was assessed by additional cytology of their vaginal cells calculated as 210−0.65*age in years). The test was at the same time as a routine cervical smear.11 All discontinued prior to this if the test had reached those showing parabasal cells, which are a marker 13 min in duration, if the subject wished to terminate of diminished ovarian hormone stimulation, and a it, or if she exhibited any of the standard symptomatic medical indications for discontinuation of an exercise random 50% of those not showing parabasal cells ECG as required by the Ethical Committee. While Analysis of densitometry time-trend data the test was performed, heart rate was monitored General procedures for evaluating DPA/DXA through the three standard chest leads of an exercise data ECG, and the subject breathed through a mouthpiece connected to a Mijnhardt Oxycon 4 on-line gas The following procedure was followed in each series analysis system for measurement of oxygen uptake.
of Hologic spine scans to test for the homogeneity Grip strength was measured using a RKK Grip of response of the individual lumbar vertebrae L2, Dynamometer at about the same stage in the study L3 and L4. For each vertebra in each woman, the as the best of three attempts, on the non-dominant BMD was plotted against time to give three individual hand because of its reported association with bone vertebral time trends. Co-variance analysis was then density. 17 used to test for differences in time trend between vertebrae. Subjects in whom a significant difference in time trend between vertebrae was identified were
Bone densitometry
excluded from the analysis of the combined L2-L4 Six-monthly measurements of the lumbar spine over data, on the grounds that for some reason (e.g. local the first 2 years with further measurements at 3.5 degenerative disease) one or more vertebrae may be years and in all but 15 women at 5 years were made behaving atypically, and that our intention was to using the Novo BMC Lab 22a dual photon absorptitrack spinal bone loss in three vertebrae that behaved ometer (DPA).8 Three-and-a-half-year measurements similarly. were also made on most subjects, and 5-year measFor the remaining women, the analysis centred on urements were made on all subjects using a Hologic the 35 who did not take HRT for at least 3 months. QDR-1000 which eventually replaced the Novo
The bone density data for vertebrae L2-L4 combined BMC Lab 22a; all duplicate measurements on the were plotted against years since menopause, and Hologic and on the Novo at the 3.5 and 5 year fitted by means of regression analysis. time-points were made on the same day. Spine
Because in some previous studies rates of bone density data from the Novo and Hologic densitoloss were related to initial bone mass, statistical meters were expressed in g/cm2. At the time of models incorporating bone density values logtransfer from the Novo to the Hologic, individual transformed before analysis were compared with conversion factors were calculated from the ratios of similar models in which the bone density data were the paired measurements to allow an individual's treated untransformed. The guiding principles in the Hologic data as well as her Novo data to be choice of statistical model were that it would be: expressed in g/cm2 (Hologic units). Appendix 1 biologically plausible; mathematically simple, only contains details of the methods used to confirm that incorporating additional terms to describe differences the Novo and Hologic data could be validly combetween individuals on good biological grounds or bined for the purpose of individual longitudinal on grounds of goodness of fit; and amenable to analyses of the bone density data, after application computation. For the spine, we chose a mathematicof these conversion factors.
ally linear model. The simplest such model which The images from the bone density scans (Hologic) adequately fitted the data used individual starting were reviewed as individual series. In some cases values for the logarithm of BMD at menopause, there was unequivocal evidence of degenerative individual rates of loss of log(BMD) for each woman spinal osteoarthritis, with patchy increases in bone and a final term representing an initially slow rate density, irregularity of vertebral body outline and of attenuation in the rate of loss of BMD which was loss of intervertebral disc spaces. These subjects the same for each woman and proportional to (time were classified as having osteoarthritis for the pursince menopause)2. If BMD loss was modelled withposes of this paper before any analysis was begun.
out being first log-transformed, the model needed to As described previously, we made 6-monthly be considerably more complicated to fit the data measurements of trabecular bone density in the distal adequately (Appendix I). radius9,18 using the 'Isotom' peripheral quantitative computed tomography (pQCT) system. After all subProcedures for fitting pQCT radius data jects had had their fifth measurement, this system became defunct due to irremediable hardware prob-
The radius data obtained from the 'Isotom' pQCT machine were presented previously, and the results lems. The 'Isotom' system was eventually replaced by the considerably more precise X-ray-based of the previous analysis used, in which 'trabecular bone plus soft tissue density' data were first converted 'Densiscan' (Scanco) pQCT system, which was used to make measurements on the same radius twice, at to 'trabecular bone only' data, log-transformed and analysed as described above to calculate relative approximately 5 years and 7 years post recruitment, before it was relocated to support a different project.
rates of decline per year. Because the 'Densiscan'
does not measure precisely the same volume of rates of spinal bone loss and total hip bone loss in trabecular bone as the 'Isotom', the subsequent the early post-menopause. These coefficients were radius data obtained with the new pQCT machine treated as dependent variables, and simple regression had to be analysed separately. The data were first analysis was used to determine the statistical significconverted into 'trabecular bone only' data using ance of relationships between these bone loss coefficonversion equations derived from multiple cross cients and continuous variables representing lifestyle, calibrations with the European Forearm Phantom anthropometric and muscle-related characteristics. (EFP)19,20 and relative rates of decline in bone density
The significance of dichotomous variables as deterper year were then calculated from the ratio of each minants of loss coefficients were assessed by measurement pair after these data were first logunpaired Student's t tests. There is extensive docutransformed.
mentation in the literature relating many of these The precision of the estimates of the rate of bone variables to bone density or rates of bone loss. loss was obtained by calculating the 95% CI for the Therefore, in developing multiple regression models, rate of loss. For models with individual rates of loss, a step-backwards approach was used, in which all the 95% CIs were based on the average of the variables significant at p<0.05 were entered together standard errors for the individual rates of loss.
with those reported significant in the literature. The least significant was removed in sequence until all remaining variables were individually significant at Plasma and urine biochemistry p<0.10. Because the analyses for the total hip and Serum osteocalcin (Incstar UK) was measured at the spine gave different results, MANOVA was used yearly intervals for 2 years, then at each densitometry to calculate the significance of the contrasts between visit until 7 years post-recruitment. Urine was colthe two coefficients for each independent variable lected at 6-month intervals after a 24 h gelatine-free significantly related to either hip or spine bone loss diet for the first 2 years and then again at 3.5, 5 and rates. All statistical calculations were implemented 9 years post-recruitment. Urinary hydroxyproline21 on JMP v3.1 (SAS Institute). was measured in a fasting early-morning urine specimen after discarding the first voiding of the morning. The ratio of hydroxyproline to creatinine was calculated. Changes in the biochemical data were exam-
Results

ined by the same statistical regression techniques as
Three women withdrew before the second bone those employed with the spinal bone densitometry density measurement and are not reported on. data. The osteocalcin22 and hydroxyproline21 assays, Seventeen at some stage took HRT for 3 or more as performed in our laboratory, were previously months, of whom one was judged to have OA of compared with reference methods for measuring the spine, and one had non-parallel trends in the whole-body bone formation and bone resorption three measured lumbar vertebrae, leaving 15 sets of using 85Sr as a tracer for calcium and making spine data which could be analysed. There were corrections for long-term exchange of radiotracer. A sixteen sets of hip data with three or more valid single measurement of osteocalcin predicted bone measurements in the HRT group. Of the 44 who did formation with a coefficient of variation of ±30% not take HRT, four were judged to have spine OA. (equivalent to a bone formation rate of 1 mmol/day, A further four had non-parallel trends in their three n=58, 22) and hydroxyproline predicted bone resorpmeasured lumbar vertebrae. One provided insuffition with a similar coefficient of variation when cient data for analysis, leaving 35 sets of spine data measured repeatedly and averaged.21,22 However, which could be analysed. An example is shown in the coefficient of variation of the mean of 18 Figure 1 . Four of the 44 were excluded from the hip successive hydroxyproline estimations was 5% comanalysis because of insufficient data. Loss of one or pared to an estimated 21% for a single estimation at more bone density results was due to death in one an excretion rate typical for a normal postmenopaucase; emigration to other countries in three cases; sal woman,21 so the predicted coefficient of variation and removal to other parts of the country in four in estimating bone resorption from a single hydroxycases, making them only occasionally available for proline estimation in the present study was 36% of measurement. a typical subject's average value in the population studied, equivalent to 1.2 mmol/day.
Women who did not take HRT Statistical analysis of the data determinants Table 1 shows the characteristics at recruitment of of bone loss the subjects studied. Using data from the European Quantitative assessment of Osteoporosis (QAO) study It was possible to calculate two coefficients per woman representing, respectively, each individual's as our referent,19,23,24 Table 2 shows at two time- Figure 1 . Spine BMD data from one subject fitted by an exponential plus a constant (a class 2 model as defined in the appendix). predicts that these initial annual loss rates are attenuRegular exercise 23 20 43 ated slowly in each woman as time passes after menopause; but that later they become attenuated increasingly rapidly. Since some of our women had points the proportions among women who did not reached 14 years after menopause, their loss rates take HRT, who were classified as having osteopenia were calculated to have reduced by 36% at the end (BMD at the measurement site less than the −1SD of the study compared to the beginning. The calcuvalue for young normal subjects) or osteoporosis lated imprecision (as a 95% CI) associated with any (BMD at the measurement site less than the −2.5SD value for young normal subjects). In the case of the individual's spine loss rate coefficient, was just under half (0.48) of the 95% CI for the population distribuadjusted 0.14; p=0.024). When spine and hip loss rate coefficients were compared there was, unexpection, suggesting that 23% of the apparent variance in the population distribution may be attributable to tedly, an inverse correlation (R2 adjusted −0.14; p=0.019) (Figure 3 ). The radius coefficients were measurement imprecision.
unrelated to those for the other two sites (0.6<p<0.9).
Femur and radius BMD loss rates
We could not validly measure bone loss rates in the Statistical determinants of bone loss femur until the Hologic densitometer became available. In the case of most women, this was 3.5 years Several factors related to anthropometric and muscle measurements, although not VO 2 max (our measure after recruitment; so we had less hip than spine data. The model which gave the best fit to the change in of cardiovascular fitness), correlated significantly with bone loss (Table 4) . Unexpectedly, however, rate of total hip BMD over time was a linear model of a similar form to that used in the spine, which had hip bone loss correlated inversely and significantly with rate of spine bone loss ( Figure 3 ) and its individual starting values and individual rates of loss of log (BMD), but no (time since menopause)2 term. determinants were different (Table 5 ).
The group contained only five smokers, yet a Twenty-eight per cent of the between-individual variance in rates of hip bone loss was attributable possible effect of smoking on spinal bone loss was detected. Since the small number of smokers made to measurement imprecision. Since the coefficient of the (time since menopause)2 term in the spine model any further analysis of their data unreliable, it was decided to present data from the stepwise regression was the same for all women, the two models were comparable. The distribution of the hip coefficients analyses on the non-smokers only. The analysis of this subset showed height ( p=0.0038, negative is also shown in Figure 2 .
For the two sets of radius trabecular bone measureestimate) and psoas area ( p=0.0031, positive estimate), which were not themselves significantly related ments (made on non-identical sites), we used models of bone loss in which loss was calculated as a ( p=0.15) as independent, significant determinants of spine loss rate (R2 adjusted=0.279). Psoas area proportion of the initial value. The first set of measurements gave results suggesting that 40% of could be substituted by lean body mass ( p<0.05). Analysis of the hip loss rate coefficients showed the inter-individual variance in loss rates was attributable to measurement imprecision. It was not possible that indices related to body mass index (R2 adjusted=0.193, p=0.0061) were the only significdirectly to estimate the contribution of measurement imprecision to the second set of radius results, but ant determinants when stepwise regression was applied. MANOVA, simplified to include just body the single-measurement in vivo precision of the 'Densiscan' was improved in relation to the earlier mass index (weight/height2), and applied to the hip, spine and the two sets of consecutive radius data machine by an order of magnitude. For these exclusively trabecular bone sites in the radius, it is clear showed a significant contrast between the hip and the other two sites ( p=0.019). The estimated positthat rates of bone loss after menopause are proportionately much higher than in the other two sites in ive effect of BMI in reducing bone loss was, in relative terms, respectively 11 times and six times the spine and femur which are composed of both cortical and trabecular bone (Figure 2) . larger over the two successive measurement periods at the radius than at the spine. We then compared calculated loss rate coefficients between measurement sites. For the two adjacent, As described previously,9 we modelled the evolution with time of plasma osteocalcin (a biochemical but not identical, radius sites studied at different times, there was a weak positive correlation (R2 marker of bone formation) and found it to rise improved when each women had her own individual intercept, although no further improvement occurred when women were allowed their own individual rates of decline. Therefore, rates of bone loss from the spine, hip and radius were modelled with the calculated hydroxyproline:creatinine intercept at menopause as the independent variate. However, none of the four regressions was statistically significant (0.053<p<0.3). Baseline cervical cytology was not predictive of bone loss rates (0.15<p<0.90 according to measurement site) and all women not on HRT showed increasing proportions of basal cells on subsequent samples taken biannually on two further occasions.
Women who took HRT
This was a group who started taking HRT at various times after entry into the study. Some have continued to the present time and others have already stopped taking HRT. Overall in this sub-group, there was no trend in spine bone density or in hip bone density in either direction.
Discussion
The precise measurement of rates of postmenopausal bone loss rates in the spine and hip is not straightforward. It seems likely that with the advent of DXA, future improvements in precision will be modest unless ways can be found to improve the reproducibility of positioning, since photon fluxes generated by current generation densitometers allow very precise measurements in vitro over short time periods. Of the equipment used in the present study, the Novo DPA densitometer is now obsolescent and gives relatively poor precision, which may help to explain the modest separation of subjects with respect to postmenopausal bone loss rates reported after 5 years of the study.9 We have extended the study, and with over a decade's worth of data in most participants, have measured individual bone loss rates in the three attributable to measurement imprecision, reducing somewhat the potential of our explanatory variables to predict rates of bone loss precisely. asymptotically towards a maximum at about 8 years post-menopause. However no statistical model we
The data for the spine and radius, but not that for the hip, suggest an attenuation in the rate of bone evaluated showed an improvement in fit when individual women were allowed to have individual loss with time after menopause. For the radius, this confirms earlier work of Johnston and his colosteocalcin levels with separate intercepts. In contrast, hydroxyproline:creatinine showed a decline leagues25 and Hansen;7 but we were not able to confirm the observations of Harris and Dawsonwith years since menopause, and the model was on femoral bone loss of time since menopause occurred in the first 5 postmenopausal years, which Table 4 Correlations between muscle-related measures in our study had passed for all our subjects by the and the coefficient of lumbar spine bone loss time we were equipped to measure the proximal femur. Harris26 used a similar design, but included In other respects, the biochemical data using urement.
markers developed at least a decade and a half ago offered no prospect that such simple tests could offer a useful guide to the identity of women with fast Hughes26 and Pouilles27 that bone loss rate declines significantly with time since menopause in the proxbone loss. However, our data provide some insights. Because we have shown that rates of bone loss are imal femur. In Pouilles's study, women were recruited at different times after menopause and studied for so variable in normal women after the menopause when contrasted between measurement sites, it is an average interval of 42 months; examination of unrealistic to expect biochemical markers, however is affected by the relative proportions of body fat (having a low aerobic metabolism) which contributes closely they reflect bone formation or resorption in the skeleton as a whole, to reflect bone loss in to a substantial dispersion within the normal population. Perhaps if it had been possible to measure specific skeletal sites, unless these sites represent a high proportion of total bone turnover. In particular, VO 2 max a second time and estimate its rate of decline, a relationship with bone loss would have the radius, as a bone of comparatively modest size which is largely composed of cortical, rather than been revealed. However, the suggestion of Pocock et al. 15 ,16 that VO 2 max was protective, was based on trabecular bone, is unlikely to contribute much to the circulating pools of biomarkers that are sampled indirect methods of estimating fitness rather than direct measurements such as we performed. in pursuit of the biochemical prediction of fast bone loss. This probably explains the mixed results
We did not expect the bone loss rates for spine and hip to show a negative correlation. Pouilles,27 obtained by different workers who have performed prospective marker studies using this bone as a with his different study design, found positive correlations between femoral and spinal loss rates, but if it referent.28
Although we found no close predictors of fast is accepted that bone loss declines with time since menopause, this was an inevitable consequence of bone loss, we were able to demonstrate that spinal bone loss is related to several indices, which might his study design, which included fast-losing women studied in the first three post-menopausal years and help to explain part of the epidemiology of vertebral fracture, and contribute to the development of popuslow-losing women studied a decade later in the evolution of their menopause. Hansen et al.7 used a lation-based as distinct from patient-based prevention strategies. Body mass index was associated positively similar recruitment design to ours, but did not report on correlations between individual rates of bone loss with reduced bone loss in the spine and radius. In recent epidemiological work we have shown that at different sites. Nor, like us, were they able to begin DXA hip measurements until relatively late body mass index is quite strongly protective against vertebral deformity in European women and men,29 after menopause. We have no explanation for our finding that when adjusted for time since menopause, and that this probably has its effect through increasing bone density.2 Our data suggest that for the spine hip and spine loss rates tend to correlate inversely. The only other circumstance under which we have and radius (but not the hip), body mass index, probably as a measure of relative obesity, is associencountered a similar phenomenon is during treatment of women with postmenopausal osteoporosis ated with a skeleton that is relatively protected against postmenopausal bone loss in its first decade with parathyroid peptide hPTH 1-34 when no oestrogen replacement is given concurrently.32 and a half. This is consistent with the concept that after menopause, adipose tissue as the main source This study had a number of limitations. Its size was comparatively small, being governed initially by of oestriol may contribute usefully to slowing bone loss, although another explanation is that heavier resource constraints associated with the expense of the slow procedure of DPA with its expensive isotope women subject their skeletons to increased mechanical loading.
sources. It was not designed to measure precisely attributable risks in populations, but rather to identify In support of this, psoas area (after adjusting for body height) was a second protective determinant any common determinants of fast bone loss which might prove useful in managing individual patients. for the spine. The psoas is one of the main flexors of the lumbar spine as well as contributing to hip Therefore, our observations on the protective effects of BMI for the spine need confirmation in a larger flexion. The biological significance of this finding is that it might indicate a continued role for mechanical population study. There were a number of changes of equipment, which were inevitable, in light of the loading of the spine in its protection against bone loss after menopause, even though there is increasing limited lifespan of such equipment in relation to the study's intended duration. This led to an interruption evidence that experimentally oestrogens are important in modulating the effects of loading on bone. 30 in the radius measurements and the need for crosscalibration procedures between equipment at the There is evidence in young athletes who develop athletic amenorrhoea that increased mechanical other sites. The success of the cross-calibration between the Hologic and Novo equipment in retroloading can provide some site-specific, if incomplete, protection against bone loss.31 spect was fortuitous, in the light of the problems experienced in a similar comparison by Peel and A negative finding of our study was the absence of a protective effect of high VO 2 max. We only Eastell33 between Hologic and Lunar DXA equipment. In Peel and Eastell's study, both sets of measured this once in the cohort, at an average of 5-6 years post-menopause. This index of aerobic equipment were capable of considerably better measurement precision than our Novo machine, making fitness is reported after adjustment for body size and their Bland and Altman analysis more critical than our General Practitioner colleagues who allowed us to study their patients, Dr Dennis Wright and Mr ours. Inevitably in a long duration cohort study, many other investigations performed at baseline used Leslie Hampton who performed the biochemistry and Roger Greenwood and Josie Pearson (statistitechniques that are no longer state of the art 12-15 years later. However, retention of our cohort has cians) who developed the database and analysed the early results of the study. The study was funded in been high, and initial compliance was also good. This is the first longitudinal study which has followed part by MRC Programme Grant G9321536. spinal bone loss after menopause for as long as 13 years in some individuals, and the first to compare in individuals its long term evolution with that of larly the spine, in avoiding excessive leanness. Although cardiovascular fitness was unrelated to Statistical time-trend models for calculating components, a short term and a long term, which rates of bone loss in the spine and hip were independent, so that their variances were Two classes of model were compared which additive. For DPA the short-term imprecision comdescribed the decline in bone density with time after ponent (c.v.%) used in our calculations was the menopause. Both classes were previously compared figure of 2.6% obtained by the technique's originators by Johnston and his colleagues in cross-sectional Krölner and Pors Nielsen,8 considerably higher than and longitudinal studies of radial bone loss in postfor DXA. We assumed the long-term component was menopausal women. 34 The first class of model (class the same for both DXA and DPA, because it was 1) fitted a polynomial function of time since menothought to be principally dependent on biological pause (or chronological age) to the BMD data, before factors and positioning of the subject. For DXA, we or after log-transformation. In these class 1 models, used our own short-term precision data, and the each woman's data were fitted with an individual long-term variance component was calculated by starting value to allow for the individual differences difference between long-and short-term overall variin BMD between women. To allow for the differences ances in the L2-4 data of Fuleihan37 for postin initial bone density values between individuals, menopausal women. The weighting factor for the co-variance analysis was applied. The simplest model DPA data relative to the DXA data calculated in this was investigated first, in which bone loss, which was way was 0.3054, being inversely proportional to the the same for each woman, was assumed to be a ratio of the calculated long-term scaled variances for simple function of time since menopause. Tests were the two techniques.
then applied using ANOVA to see if the data were better fitted by allowing individual rates of bone loss
Validity of combining Hologic and Novo
to differ. A further analysis was performed in which spine data bone loss was allowed to be curvilinear. This was achieved by fitting the data to the two independent Next, we considered whether it was valid to combine variables 'time' and 'time squared'. Again, tests were Novo and Hologic data in the same time trend performed to see if the data were better fitted by analysis, since there is some evidence that this may allowing the individual patients to have different not be valid with other combinations of instrurates of bone loss as functions of the square of time ments.33 A regression analysis was performed on the since menopause. In comparing models in which short-term (1-2.4-year) rates of change in bone BMD and the logarithm of BMD were alternative density based on data taken at just the two time dependent variables, preference was given to models points from women who had both DXA and DPA that could be fitted with fewer terms (and thus used measurements at 3.5 and 5 years. This showed no fewer statistical degrees of freedom) unless a more significant difference from the line of identity in the complex model significantly improved the fit to regression equation relating DPA-derived rates to the data. DXA-derived rates. We therefore performed a Bland
In the other class of model (class 2), data from and Altman analysis38 of the relationship between each individual woman was fitted to a non-linear the individual differences in slope for the paired function comprising an exponential decline in BMD Novo and Hologic data. We used the best estimate after menopause becoming asymptotic to a postof the true slope by weighting these calculated means menopausal constant value. To allow a comparison to allow for their different measurement precisions, of the two classes of model, for the class 2 model as recommended by Altman.39 We first excluded the residual sums of squares were calculated by three women who were judged to have developed cumulating the residuals derived from the individual probable osteoarthritis on the basis of inspecting the fits to the data of each woman. Hologic images. This was because the procedures for editing scan images were different on the two systems, and this diagnosis was the main trigger to
Choice of model to fit lumbar BMD loss image editing in our study prior to analysis.
rates
Our Bland and Altman analysis, which was based on 25 subjects who never took HRT and 8 who did
When the various models of BMD time trend were compared in women classified as not having taken (so included both subjects whose bone density was increasing and subjects in whom it was decreasing), HRT, it was found among the models of L2-4 spinal bone loss that a considerably simpler model could showed no significant trend ( p=0.68) and no significant difference in trend between HRT and nonbe fitted when the logarithm of BMD was fitted in place of BMD untransformed, because the latter HRT groups ( p=0.06). The median difference between the DPA and the DXA trend data was required individual terms for each woman in (time since menopause)2 whereas for the model fitting the 0.000 g.cm−2.y−1 (non-HRT group). logarithm of BMD, including such individual terms of attenuation in the rate of loss of BMD which was the same for each woman and proportional to (time did not improve the fit, and the adjusted R2 value was improved compared to the model fitting the since menopause)2. This model gave a near-identical goodness of fit to the class 2 (non-linear) model untransformed BMD data. The simplest class 1 model which adequately fitted the data incorporated indi- (Figure 1 ), so it was not possible to establish a preference on those grounds, but the class 1 model vidual starting values for log(BMD) at menopause, individual rates of loss of log(BMD) for each woman was much more tractable computationally, since it did not require iterative fitting. and a final term representing an initially slow rate
